JIMD Podcasts is home to the Journal of Inherited Metabolic Disease podcast and the JIMD Shortcast. We're also proud to showcase Metabolic Mysteries and the new Footprints in IMD podcast.
JIMD Podcasts
Claim This Podcastby Journal of Inherited Metabolic Disease
5.0(29 reviews)
272 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇬🇧
61
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality86
Social0
YouTube0
Engagement90
Podcast Overview
JIMD Podcasts is home to the Journal of Inherited Metabolic Disease podcast and the JIMD Shortcast. We're also proud to showcase Metabolic Mysteries and the new Footprints in IMD podcast.
Language
🇺🇲
Publishing Since
6/23/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
61
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality86
Social0
YouTube0
Engagement90
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
25 minutes
Performing excellently!
good
Publishing Consistency
Every 8 days
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for JIMD Podcasts
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 16, 2026
Shortcast: Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB
In this Shortcast Dr Mark Wijnen presents two cases where Teriparatide was used to treat bone complications in MPD IVB but explains how temporally associated cardiac disease compels his groups to advise caution in its use. Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB Mark Wijnen, Evert F. S. van Velsen, J. Gert-Jan Milhous, Esmee Oussoren, Bram C. J. van der Eerden, Margreet A. E. M. Wagenmakers First published: 13 April 2026 https://doi.org/10.1002/jmd2.70088
June 9, 2026
High Glycine, Different Diagnoses
A raised glycine level can point to a surprisingly broad range of conditions. In this episode, James Nurse is joined by Arthavan Selvanathan and Curtis Coughlin to discuss their review, The History and Nosology of the Glycine Disorders: A Framework for Clinicians. Together they explore why not all hyperglycinaemia is nonketotic hyperglycinaemia (NKH), how our understanding of glycine disorders has evolved, and how clinicians can navigate the differential diagnosis of elevated glycine in practice. From classic and attenuated NKH to lipoate deficiency syndromes, pyridoxine-related disorders, and important phenocopies such as valproate exposure, this episode provides a practical framework for approaching high glycine levels. The History and Nosology of the Glycine Disorders: A Framework for Clinicians Arthavan Selvanathan, et al https://doi.org/10.1002/jimd.70138
June 2, 2026
IMD Research Round-Up: Homocystinuria
Season 2 of the JIMD Research Round-Up begins with a deep dive into classical homocystinuria (CBS deficiency). Hosts Silvia Radenkovic and Rodrigo Starosta are joined by two internationally recognised experts, Dr Andrew Morris (Royal Manchester Children's Hospital, UK) and Professor Kim Chapman (Children's Hospital Los Angeles, USA). In this episode, they explore: - The clinical spectrum of homocystinuria, from childhood presentations to adults diagnosed after thrombosis - Why the condition is still frequently missed or misdiagnosed - The overlap with Marfan syndrome and the unanswered questions surrounding disease mechanisms - The strengths and limitations of current newborn screening programmes - Dietary treatment, pyridoxine responsiveness, and the challenges faced by patients and families - Emerging therapies including enzyme substitution therapy, chaperone therapies, and ongoing clinical trials - Why there is genuine optimism for the future of homocystinuria care and research A fascinating discussion covering six decades of progress in homocystinuria and the next generation of treatments that may transform care.
272 total episodes available
Recent guests on JIMD Podcasts
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr JP Stevens
Guest
Lottie Morrison
Guest
Dr Alana Burns
Guest
Annabel Wong
Guest
Freya Hassall
Guest
Dr Luciana Hannibal
Guest
Dr Julien Park
Guest
Dr Dexter Tarr
Guest
François Feillet
Guest
Similar Podcasts
Discover related shows you might enjoy
NEJM This Week
NEJM Group
Practical Neurology Podcast
BMJ Group
Annals On Call Podcast
American College of Physicians
Global News Podcast
BBC World Service
Neurology® Podcast
American Academy of Neurology
Revisionist History
Pushkin Industries
Conversations
ABC Australia
More or Less: Behind the Stats
BBC Radio 4
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
The Proof with Simon Hill
Live better for longer
The Daily
The New York Times
Freakonomics Radio
Freakonomics Radio + Stitcher
The Ezra Klein Show
New York Times Opinion
The Life Scientific
BBC Radio 4
Cautionary Tales with Tim Harford
Pushkin Industries
Deep-dive analytics for JIMD Podcasts
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is JIMD Podcasts?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.